BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 16825367)

  • 1. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
    Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
    J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Khot PD; Ko DL; Hackman RC; Fredricks DN
    BMC Infect Dis; 2008 May; 8():73. PubMed ID: 18510764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats.
    Khan ZU; Ahmad S; Theyyathel AM
    Mycoses; 2008 Mar; 51(2):129-35. PubMed ID: 18254749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
    Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
    Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
    Vallor AC; Kirkpatrick WR; Najvar LK; Bocanegra R; Kinney MC; Fothergill AW; Herrera ML; Wickes BL; Graybill JR; Patterson TF
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2593-8. PubMed ID: 18474582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
    Verweij PE; Latgé JP; Rijs AJ; Melchers WJ; De Pauw BE; Hoogkamp-Korstanje JA; Meis JF
    J Clin Microbiol; 1995 Dec; 33(12):3150-3. PubMed ID: 8586691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
    Clancy CJ; Jaber RA; Leather HL; Wingard JR; Staley B; Wheat LJ; Cline CL; Rand KH; Schain D; Baz M; Nguyen MH
    J Clin Microbiol; 2007 Jun; 45(6):1759-65. PubMed ID: 17428933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis.
    Rantakokko-Jalava K; Laaksonen S; Issakainen J; Vauras J; Nikoskelainen J; Viljanen MK; Salonen J
    J Clin Microbiol; 2003 Sep; 41(9):4304-11. PubMed ID: 12958261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast.
    Steinmann J; Buer J; Rath PM; Paul A; Saner F
    Transpl Infect Dis; 2009 Apr; 11(2):175-8. PubMed ID: 19210691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
    Chong GM; van der Beek MT; von dem Borne PA; Boelens J; Steel E; Kampinga GA; Span LF; Lagrou K; Maertens JA; Dingemans GJ; Gaajetaan GR; van Tegelen DW; Cornelissen JJ; Vonk AG; Rijnders BJ
    J Antimicrob Chemother; 2016 Dec; 71(12):3528-3535. PubMed ID: 27530755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.